Abstract
The global population is aging with millions of people today living into their 90 s. Thyroid disease, particularly hypothyroidism, is widespread among all age groups, and it is expected to steadily increase as the population gets older. Clinical diagnosis of hypothyroidism is challenging, as the TSH reference range needs to be evaluated according to age, while evaluation of TSH levels must also take into account body weight and other variants such as polypharmacy, comorbidities, and general health condition. Since thyroid hormone has a potent regulatory effect on cholesterol metabolism, the possibility of thyroid dysfunction should be considered in cases of unexplained dyslipidemia. Once hypothyroidism has been confirmed, treatment requires caution, frequent cardiovascular monitoring, and individualized (precision) medicine. Treatment of subclinical hypothyroidism (SCH) in the elderly should be undertaken with care, guided by age and the degree of SCH: a TSH higher than 10 mU/l seems a reasonable threshold, though it should be regularly re-evaluated, while the LT4 dose needs to be tailored, taking into account the patient’s health condition and the potential presence of dyslipidemia as well as other metabolic derangements.
Similar content being viewed by others
References
Population Division. U.S. Census Bureau, The Census Bureau on prospects for US population growth in the twenty-first century. Popul. Dev. Rev. 26, 197–200 (2000). https://doi.org/10.1111/j.1728-4457.2000.00197.x
W. Lutz, W. Sanderson, S. Scherbov, The coming acceleration of global population ageing. Nature 451, 716–719 (2008). https://doi.org/10.1038/nature06516
P. Laurberg, S. Andersen, I. Bülow Pedersen, A. Carle, Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging 22, 23–38 (2005). https://doi.org/10.2165/00002512-200522010-00002
J.V. Hennessey, R. Espaillat, Diagnosis and management of subclinical hypothyroidism in elderly adults: a review of the literature. J. Am. Geriatr. Soc. 63, 1663–1673 (2015). https://doi.org/10.1111/jgs.13532
W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J.G. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. 7, 481–493 (1977)
J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182
T. Vadiveloo, P.T. Donnan, M.J. Murphy, G.P. Leese, Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the thyroid epidemiology, audit, and research study (TEARS). J. Clin. Endocrinol. Metab. 98, 1147–1153 (2013). https://doi.org/10.1210/jc.2012-3191
O. Leng, S. Razvi, Hypothyroidism in the older population. Thyroid Res. 8(12), 22 (2019). https://doi.org/10.1186/s13044-019-0063-3
X. Zhai, L. Zhang, L. Chen, X. Lian, C. Liu, B. Shi, L. Shi, N. Tong, S. Wang et al. An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China. Thyroid (2018). https://doi.org/10.1089/thy.2017.0715
L.H. Duntas, Thyroid function in aging: a discerning approach. Rejuvenation Res 21, 22–28 (2018). https://doi.org/10.1089/rej.2017.1991
C.D. Smith, R. Grondin, W. LeMaster, B. Martin, B.T. Gold, K.B. Ain, Reversible cognitive, motor, and driving impairments in severe hypothyroidism. Thyroid 25, 28–36 (2015). https://doi.org/10.1089/thy.2014.0371
R. Gourmelon, S. Donadio-Andréi, K. Chikh, M. Rabilloud, E. Kuczewski, A.S. Gauchez et al. Subclinical hypothyroidism: is it really subclinical with aging? Aging Dis. 10, 520–529 (2019). https://doi.org/10.14336/AD.2018.0817
D. Strich, G. Karavani, S. Edri, D. Gillis, TSH enhancement of FT4 to FT3 conversion is age dependent. Eur. J. Endocrinol. 175, 49–54 (2016). https://doi.org/10.1530/EJE-16-0007
J.D. Veldhuis, Changes in pituitary function with aging and implications for patient care. Nat. Rev. Endocrinol. 9, 205–215. https://doi.org/10.1038/nrendo.2013.38
F. Monzani, P. Del Guerra, N. Caraccio, L. Del Corso, A. Casolaro, S. Mariotti, F. Pentimone, F. Age-related, modifications in the regulation of the hypothalamic-pituitary-thyroid axis. Horm. Res. 46, 107–1012 (1996). https://doi.org/10.1159/000185005
S. Mariotti, G. Barbesino, P. Caturegli, L. Bartalena, P. Sansoni, F. Fagnoni, D. Monti, U. Fagiolo, C. Franceschi, A. Pinchera, Complex alteration of thyroid function in healthy centenarians. J. Clin. Endocrinol. Metab. 77, 1130–1134 (1993). https://doi.org/10.1210/jcem.77.5.8077303
S. Volpato, J.M. Guralnik, L.P. Fried, A.T. Remaley, A.R. Cappola, L.J. Launer, Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58, 1055–1061 (2002). https://doi.org/10.1212/wnl.58.7.1055
A. Carlé, P. Laurberg, I.B. Pedersen, H. Perrild, L. Ovesen, L.B. Rasmussen, T. Jorgensen, N. Knudsen, Age modifies the pituitary TSH response to thyroid failure. Thyroid 17, 139–144 (2007). https://doi.org/10.1089/thy.2006.0191
A.P. Bremner, P. Feddema, P.J. Leedman, S.J. Brown, J.P. Beilby, E.M. Lim, S.G. Wilson, P.C. O’Lear, J.P. Walsh, Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J. Clin. Endocrinol. Metab. 97, 1554–1562 (2012). https://doi.org/10.1210/jc.2011-3020
P.S. Hansen, T.H. Brix, T.I. Sørensen, K.O. Kyvik, L. Hegedüs, Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89, 1181–1187 (2004). https://doi.org/10.1210/jc.2003-031641
J.V. Hennessey, R. Espaillat, Subclinical hypothyroidism: a historical view and shifting prevalence. Int. J. Clin. Pract. 69, 771–782 (2015). https://doi.org/10.1111/ijcp.12619
G. Atzmon, N. Barzilai, J.G. Hollowell, M.I. Surks, I. Gabriely, Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab. 94, 1251–1254 (2009). https://doi.org/10.1210/jc.2008-2325
J. Gussekloo, E. van Exel, A.J. de Craen, A.E. Meinders, M. Froehlich, R.G. Westendorp, Thyroid status, disability and cognitive function, and survival in old age. JAMA 292, 2591–2599 (2004). https://doi.org/10.1001/jama.292.21.2591
N.A. van Vliet, E. van der Spoel, M. Beekman, P.E. Slagboom, G.J. Blauw, J. Gusseklo, R.G.J. Westendorp, D. van Heemst, Thyroid status and mortality in nonagenarians from long-lived families and the general population. Aging 9, 2223–2234 (2017). https://doi.org/10.18632/aging.101310
M.P. Rozing, J.J. Houwing-Duistermaat, P.E. Slagboom, M. Beekman, M. Froelich, A.J. de Craen, Familial longevity is associated with decreased thyroid function. J. Clin. Endocrinol. Metab. 95, 4979–4984 (2010). https://doi.org/10.1210/jc.2010-0875
R. Over, S. Mannan, H. Nsouli-Maktabi, K.D. Burman, J. Jonklaas, Age and thyrotropin response to hypothyroxinemia. J. Clin. Endocrinol. Metab. 95, 3675–3683 (2010). https://doi.org/10.1210/jc.2010-0281
L.H. Duntas, G.A. Brenta, A renewed focus on the association between thyroid hormones and lipid metabolism. Front. Endocrinol. 9, 511 (2018). https://doi.org/10.3389/fendo.2018.00511
G.A. Sigal, T.M. Tavoni, B.M.O. Silva, R. Kalil Filho, L.G. Brandão, R.C. Maranhão, Effects of short-term hypothyroidism on the lipid transfer to high-density lipoprotein and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer. Thyroid 29, 53–58 (2019). https://doi.org/10.1089/thy.2018.0190
T. Tagami, H. Kimura, S. Ohtani, T. Tanaka, T. Tanaka, S. Hata, M. Saito, Y. Miyazaki, R. Araki, M. Tanaka, K. Yonezawa, M. Sawamura, T. Ise, A. Ogo, T. Shimbo, A. Shimatsu, M. Naruse; PHPH study group, Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr. J. 58, 449–4457 (2011)
P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018). https://doi.org/10.1038/nrendo.2018.18
B.O. Asvold, L.J. Vatten, T.I. Nilsen, T. Bjoro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156, 181–186 (2007). https://doi.org/10.1530/eje.1.02333
D.L. Willard, A.M. Leung, E.N. Pearce, Thyroid function testing in patients with newly diagnosed hyperlipidemia. JAMA Intern. Med. 174, 287–289 (2014). https://doi.org/10.1001/jamainternmed.2013.12188
L.H. Duntas, L. Wartofsky, Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 17, 1075–1084 (2007). https://doi.org/10.1089/thy.2007.0116
V. Arnao, A. Tuttolomondo, M. Daidone, A. Pinto, Lipoproteins in atherosclerosis process. Curr. Med. Chem. 26, 1525–1543 (2019). https://doi.org/10.2174/0929867326666190516103953
J. Pihlajamaki, T. Boes, E.Y. Kim, F. Dearie, B.W. Kim, J. Schroeder, E. Mun, I. Nasser, P.J. Park, A.C. Bianco, A.B. Goldfine, M.E. Patti, Thyroid hormone-related regulation of gene expression in human fatty liver. J. Clin. Endocrinol. Metab. 94, 3521–3529 (2009). https://doi.org/10.1210/jc.2009-0212
R.A. Sinha, S.H. You, J. Zhou, M.M. Siddique, B.H. Bay, X. Zhu, M.L. Privalsky, S.Y. Cheng, R.D. Stevens, S.A. Summers, C.B. Newgard, M.A. Lazar, P.M. Yen, Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J. Clin. Investig. 122, 2428–2438 (2012). https://doi.org/10.1172/JCI60580
J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24, 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028
D.S. Cooper, Thyroid disease in the oldest old: the exception to the rule. JAMA 292, 2651–2654 (2004). https://doi.org/10.1001/jama.292.21.2651.
L.L. Somwaru, A.M. Arnold, N. Joshi, L.P. Fried, A.R. Cappola, High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J. Clin. Endocrinol. Metab. 94, 1342–1345 (2009). https://doi.org/10.1210/jc.2008-1696
H.M. Robertson, A.K. Narayanaswamy, O. Pereira, S.A. Copland, R. Herriot, A.W. McKinlay, J.S. Bevan, P. Abraham, Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid 24, 1765–1771 (2014). https://doi.org/10.1089/thy.2013.0661
A. Akirov, H. Gimbel, A. Grossman, T. Shochat, I. Shimon, Elevated TSH in adults treated for hypothyroidism is associated with increased mortality. Eur. J. Endocrinol. 176, 57–66 (2017). https://doi.org/10.1530/EJE-16-0708
L.H. Duntas, G. Brenta, Thyroid hormones: a potential ally to LDL-cholesterol-lowering agents. Horm. (Athens) 15, 500–510 (2016). https://doi.org/10.14310/horm.2002.1707
B. Biondi, A.R. Cappola, D.S. Cooper, Subclinical Hypothyroidism: a review. JAMA 322, 153–160 (2019). https://doi.org/10.1001/jama.2019.9052
B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76–131 (2008). https://doi.org/10.1210/er.2006-0043
D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379, 1142–1154 (2012). https://doi.org/10.1016/S0140-6736(11)60276-6
L.L. Somwaru, C.M. Rariy, A.M. Arnold, A.R. Cappola, The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J. Clin. Endocrinol. Metab. 97, 1962–1969 (2012). https://doi.org/10.1210/jc.2011-3047
M.R. Blum, B. Gencer, L. Adam, M. Feller, T.H. Collet, B.R. da Costa, E. Moutzouri, J. Dopheide, M. Depairon, G.P. Sykiotis, P. Kearney, J. Gussekloo, R. Westendorp, D.J. Stott, D.C. Bauer, N. Rodondi, Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial. J. Clin. Endocrinol. Metab. 103, 2988–2997 (2018). https://doi.org/10.1210/jc.2018-00279
V.S. Virgini, L.W. Wijsman, N. Rodondi, D.C. Bauer, P.M. Kearney, J. Gussekloo, W.P. den Elzen, J.W. Jukema, R.G. Westendorp, I. Ford, D.J. Stott, S.P. Mooijaart, PROSPER study group: subclinical thyroid dysfunction and functional capacity among elderly. Thyroid 24, 208–214 (2014). https://doi.org/10.1089/thy.2013.0071
A. Grossman, A. Weiss, N. Koren-Morag, I. Shimon, Y. Beloosesky, J. Meyerovitch, Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study. Am. J. Med. 129, 423–430 (2016). https://doi.org/10.1016/j.amjmed.2015.11.027.
D.J. Stott, N. Rodondi, P.M. Kearney, I. Ford, R.G.J. Westendorp, S.P. Mooijaart et al. Trust study group. thyroid hormone therapy for older adults with subclinical hypothyroidism. N. Engl. J. Med. 376, 2534–2544 (2017). https://doi.org/10.1056/NEJMoa1603825
N.A. van Vliet, R. Noordam, D. van Heemst, Thyroid hormone therapy for older adults with subclinical hypothyroidism. N. Engl. J. Med. 377, e20 (2017). https://doi.org/10.1056/NEJMc1709989
A. Grossman, I. Feldhamer, J. Meyerovitch, Treatment with levothyroxine in subclinical hypothyroidism is associated with increased mortality in the elderly. Eur. J. Intern. Med. 50, 65–68 (2018). https://doi.org/10.1016/j.ejim.2017.11.010
E. Bruinstroop, R. Dalan, Y. Cao, Y.M. Bee, K. Chandran, L.W. Cho, S.B. Soh, E.K. Teo, S.A. Toh, M.K.S. Leow, R.A. Sinha, S.A. Sadananthan, N. Michael, H.M. Stapleton, C. Leung, P.W. Angus, S.K. Patel, L.M. Burrell, S.C. Lim, C.F. Sum, S.S. Velan, P.M. Yen, Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD. J. Clin. Endocrinol. Metab. 103, 2698–2706 (2018). https://doi.org/10.1210/jc.2018-00475
R.S. Du Puy, I. Postmus, D.J. Stott, M.R. Blum, R.K.E. Poortvliet, W.P.J. Den Elzen, R.P. Peeters, Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over. BMC Endocr. Disord. 18, 67 (2018). https://doi.org/10.1186/s12902-018-0285-8
S.H. Pearce, G. Brabant, L.H. Duntas, F. Monzani, R.P. Peeters, S. Razvi, J.L. Wemeau, 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2, 215–228 (2013). https://doi.org/10.1159/000356507
J. Jonklaas, S. Razvi, Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes. Endocrinol. 7, 473–483 (2019). https://doi.org/10.1016/S2213-8587(18)30371-1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Duntas, L.H., Yen, P.M. Diagnosis and treatment of hypothyroidism in the elderly. Endocrine 66, 63–69 (2019). https://doi.org/10.1007/s12020-019-02067-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-02067-9